Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States-Reference-Cited by-同舟云学术

Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States

Published:2019-01-08 Issue:4 Volume:35 Page:603-609
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Teeple A.¹,Ginsburg S.²,Howard L.³,Huff L.⁴,Reynolds C.⁴,Walls D.⁵,Ellis L.A.¹,Curtis J. R.⁶

Affiliation:

1. Janssen Scientific Affairs, LLC, Horsham, PA, USA;

2. Global Health Living Foundation, Upper Nyack, NY, USA;

3. National Psoriasis Foundation, Alexandria, VA, USA;

4. Benfield, a Division of Gallagher Benefit Services, Inc., Webster Groves, MO, USA;

5. BDJ Solutions, LLC; Melrose, MA, USA;

6. University of Alabama at Birmingham, Birmingham, AL, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1560221

Reference20 articles.

2. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review

3. Cost-motivated treatment changes in Medicare Part B: implications for non-medical switching. The Moran Company; 2016. Arlington, Virginia. [cited 2018 Oct 4]. Available from: http://1yh21u3cjptv3xjder1dco9mx5s.wpengine.netdna-cdn.com/wp-content/uploads/2016/10/Switching-Study-Report-FINAL.pdf.

4. Tennessee patient sentiment toward non-medical switching. GHLF CreakyJoints; 2016. Upper Nyack, NY. [cited 2018 Oct 4]. Available from: https://creakyjoints.org/advocacy/tennessee-patient-sentiment-toward-non-medical-drug-switching/.

5. Cost-motivated treatment changes in commercial claims: implications for non-medical switching. The Moran Company; 2017. Arlington Virginia. [cited 2018 Oct 4]. Available from: http://1yh21u3cjptv3xjder1dco9mx5s.wpengine.netdna-cdn.com/wp-content/uploads/2013/08/Moran_Commercial-claims-analysis-report_Aug-2017.pdf.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obstacles to Biosimilar Acceptance and Uptake in Oncology;JAMA Oncology;2024-07-01

2. Barriers and Enablers Affecting the Uptake of Biosimilar Medicines Viewed Through the Lens of Actor Network Theory: A Systematic Review;BioDrugs;2024-06-15

3. Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences;International Journal of Clinical Pharmacy;2024-01-17

4. Biosimilars;Journal of Infusion Nursing;2024-01

5. Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto;Clinical Rheumatology;2023-11-21